Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001636282-26-000111 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 4, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
85,197
Total Value
$2,892,314.12
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
See Remarks | Common Stock | โ | Sep 1, 2026 | Exercise/Conversion | 27,999 | $14.50 | $405,985.50 | 30,844 | Direct | โ | View Details | |
See Remarks | Common Stock | โ | Sep 1, 2026 | Sale | 4,845 | $86.40 | $418,608.00 | 25,999 | Direct | โ | View Details | |
See Remarks | Common Stock | โ | Sep 1, 2026 | Sale | 16,548 | $87.20 | $1,442,985.60 | 9,451 | Direct | โ | View Details | |
See Remarks | Common Stock | โ | Sep 1, 2026 | Sale | 6,206 | $88.17 | $547,183.02 | 3,245 | Direct | โ | View Details | |
See Remarks | Common Stock | โ | Sep 1, 2026 | Sale | 400 | $89.38 | $35,752.00 | 2,845 | Direct | โ | View Details | |
See Remarks | Common Stock | โ | Sep 2, 2026 | Exercise/Conversion | 400 | $14.50 | $5,800.00 | 3,245 | Direct | โ | View Details | |
See Remarks | Common Stock | โ | Sep 2, 2026 | Sale | 400 | $90.00 | $36,000.00 | 2,845 | Direct | โ | View Details | |
See Remarks | Stock Option (Right to Buy) | Derivative | Sep 1, 2026 | Exercise/Conversion | 27,999 | $0.00 | $0.00 | 511,811 | Direct | โ | View Details | |
See Remarks | Stock Option (Right to Buy) | Derivative | Sep 2, 2026 | Exercise/Conversion | 400 | $0.00 | $0.00 | 511,411 | Direct | โ | View Details |